4.8 Article

3' UTR shortening represses tumor-suppressor genes in trans by disrupting ceRNA crosstalk

Journal

NATURE GENETICS
Volume 50, Issue 6, Pages 783-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41588-018-0118-8

Keywords

-

Funding

  1. US National Institutes of Health (NIH) [R01HG007538, R01CA193466, U54CA217297]
  2. Cancer Prevention Research Institute of Texas (CPRIT) grant [RP150292]
  3. CPRIT [RP100107, RP140800]
  4. Welch Foundation [AU-1889]
  5. NIH [RO1GM046454]
  6. Houston Endowment, Inc.

Ask authors/readers for more resources

Widespread mRNA 3' UTR shortening through alternative polyadenylation(1) promotes tumor growth in vivo(2). A prevailing hypothesis is that it induces proto-oncogene expression in cis through escaping microRNA-mediated repression. Here we report a surprising enrichment of 3' UTR shortening among transcripts that are predicted to act as competingendogenous RNAs (ceRNAs) for tumor-suppressor genes. Our model-based analysis of the trans effect of 3' UTR shortening (MAT3UTR) reveals a significant role in altering ceRNA expression. MAT3UTR predicts many trans-targets of 3' UTR shortening, including PTEN, a crucial tumor-suppressor gene(3) involved in ceRNA crosstalk(4) with nine 3' UTRshortening genes, including EPS15 and NFIA. Knockdown of NUDT21, a master 3' UTR-shortening regulator(2), represses tumor-suppressor genes such as PHF6 and LARP1 in trans in a miRNA-dependent manner. Together, the results of our analysis suggest a major role of 3' UTR shortening in repressing tumor-suppressor genes in trans by disrupting ceRNA crosstalk, rather than inducing proto-oncogenes in cis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available